Global Patent Index - EP 4115950 A4

EP 4115950 A4 20240313 - INTESTINAL TRACT FUNCTION IMPROVING AGENT

Title (en)

INTESTINAL TRACT FUNCTION IMPROVING AGENT

Title (de)

MITTEL ZUR VERBESSERUNG DER DARMTRAKTFUNKTION

Title (fr)

AGENT AMÉLIORANT LA FONCTION DU TRACTUS INTESTINAL

Publication

EP 4115950 A4 20240313 (EN)

Application

EP 21763653 A 20210301

Priority

  • JP 2021007772 W 20210301
  • JP 2020035185 A 20200302

Abstract (en)

[origin: EP4115950A1] An agent which can play a comparable or superior role to LS in improvement of intestinal tract function, enhancement of immune function, suppression of production of a putrefactive product, improvement of bowel movement or the like and an agent which can play a role in protection of the intestinal tract from a food emulsifier, a lipid peroxide or the like are provided. An intestinal tract function-improving agent, an immunoenhancing agent, a putrefactive product production-suppressing agent, a bowel movement-improving agent and an intestinal tract protection agent each containing a cyclodextrin as an active ingredient are provided. they can play a comparable or superior role to LS in improvement of intestinal tract function, enhancement of immune function, suppression of production of a putrefactive products, improvement of bowel movement or the like and the agent which can play a role in protection of the intestinal tract from a food emulsifier, a lipid peroxide or the like. Using the agents as an active ingredient, an anti-inflammatory agent, an immunostimulant, a body odor-improving agent, a stool odor-improving agent, a laxative, an intestinal tract protection agent and the like can also be provided.

IPC 8 full level

A61K 31/724 (2006.01); A23L 33/125 (2016.01); A61P 1/00 (2006.01); A61P 1/10 (2006.01); A61P 37/04 (2006.01)

CPC (source: EP US)

A23L 33/125 (2016.07 - EP US); A23L 33/40 (2016.07 - US); A61K 31/724 (2013.01 - EP US); A61P 1/00 (2017.12 - EP US); A61P 1/10 (2017.12 - EP); A61P 1/14 (2017.12 - US); A61P 37/04 (2017.12 - EP); A23V 2002/00 (2013.01 - EP US)

C-Set (source: EP)

A23V 2002/00 + A23V 2200/32 + A23V 2200/324 + A23V 2250/5112

Citation (search report)

  • [X] CA 2835747 C 20171017 - SOHO FLORDIS INT PTY LTD [AU]
  • [X] WO 2012154739 A1 20121115 - UWM RES FOUNDATION INC [US], et al
  • [X] SASAKI DAISUKE ET AL: "Low amounts of dietary fibre increase in vitro production of short-chain fatty acids without changing human colonic microbiota structure", SCIENTIFIC REPORTS, vol. 8, no. 1, 11 January 2018 (2018-01-11), US, XP093124632, ISSN: 2045-2322, Retrieved from the Internet <URL:https://www.nature.com/articles/s41598-017-18877-8> DOI: 10.1038/s41598-017-18877-8
  • See references of WO 2021177248A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 4115950 A1 20230111; EP 4115950 A4 20240313; CN 115209746 A 20221018; JP WO2021177248 A1 20210910; US 2023089789 A1 20230323; WO 2021177248 A1 20210910

DOCDB simple family (application)

EP 21763653 A 20210301; CN 202180018715 A 20210301; JP 2021007772 W 20210301; JP 2022504362 A 20210301; US 202117908391 A 20210301